• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • Lauren E. Abrey, Leah S Ben-Porat, +8 authors Lisa M DeAngelis
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2006 (First Publication: 20 December 2006)
  • PURPOSE The purpose of this study was to analyze prognostic factors for patients with newly diagnosed primary CNS lymphoma (PCNSL) in order to establish a predictive model that could be applied toContinue Reading
  • Lisa M DeAngelis, Wendy F Seiferheld, S. Clifford Schold, Barbara Anne Fisher, Christopher J. Schultz
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2002 (First Publication: 15 December 2002)
  • PURPOSE Primary CNS lymphoma (PCNSL) is an aggressive primary brain tumor. Cranial irradiation alone rarely results in long-term disease control or prolonged survival. We prospectively studied theContinue Reading
  • Lisa M DeAngelis
  • Medicine
  • The New England journal of medicine
  • 2001
  • This volume provides examples of over 100 brain tumors, running the gamut from the very common to the rare. Each example is presented in a case based format and the wide variety of cases presentedContinue Reading
  • Lauren E. Abrey, Tracy T Batchelor, +17 authors Franco Cavalli
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2005 (First Publication: 1 August 2005)
  • Standardized guidelines for the baseline evaluation and response assessment of primary CNS lymphoma (PCNSL) are critical to ensure comparability among clinical trials for newly diagnosed patients.Continue Reading
  • Gaurav Shah, Joachim Yahalom, +7 authors Lauren E. Abrey
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2007 (First Publication: 20 October 2007)
  • PURPOSE Our goals were to evaluate the safety of adding rituximab to methotrexate (MTX)-based chemotherapy for primary CNS lymphoma, determine whether additional cycles of induction chemotherapyContinue Reading